Design space and robustness analysis of batch and counter-current frontal chromatography processes for the removal of antibody aggregates.

Aggregate Antibody Continuous chromatography Counter-current chromatography Design space Frontal chromatography

Journal

Journal of chromatography. A
ISSN: 1873-3778
Titre abrégé: J Chromatogr A
Pays: Netherlands
ID NLM: 9318488

Informations de publication

Date de publication:
24 May 2020
Historique:
received: 11 11 2019
revised: 31 01 2020
accepted: 02 02 2020
pubmed: 18 2 2020
medline: 8 7 2020
entrez: 17 2 2020
Statut: ppublish

Résumé

Increasing molecular diversity and market competition requires biopharmaceutical manufacturers to intensify their processes. In this respect, frontal chromatography on cation exchange resins has shown its potential to effectively remove aggregates. However, yield losses during the wash step need to be accepted in order to ensure robust product quality. In this work, we present a novel counter-current frontal chromatography process called Flow2, which uses inline dilution during an interconnected wash phase to allow high monomer recovery without contaminating the product pool with impurities. Its model-based design spaces under purity and yield constraints are compared with those corresponding to traditional batch processes in terms of size and process attributes yield and productivity. The Flow2 process shows the largest extent of feasible operating points independent of feed conditions. Thereby, it allows the implementation of higher ionic strength wash, thus widening the range of operating conditions resulting in yields above 95% compared to batch processes. Productivities of batch and counter-current processes are the same at short regeneration times and equal residence time. However, long regeneration times, while influencing the size of the Flow2 design space, are not detrimental for its productivity resulting in twice as high values as obtained for the batch process. Furthermore, process robustness is evaluated by the ability of the process to maintain the required product quality when subjected to process parameter perturbations. It is found that the Flow2 process is able to retain a larger design space associated also with higher yields showing its ability to improve process attributes without sacrificing robustness at the same time.

Identifiants

pubmed: 32061360
pii: S0021-9673(20)30130-8
doi: 10.1016/j.chroma.2020.460943
pii:
doi:

Substances chimiques

Antibodies, Monoclonal 0
Cation Exchange Resins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

460943

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests. The authors declare that they have no conflicts of interest pertaining to the contents of this article.

Auteurs

Sebastian Vogg (S)

Institute for Chemical and Bioengineering, Department of Chemistry and Applied Biosciences, ETH Zurich, Vladimir-Prelog-Weg 1-5/10, Zürich 8093, Switzerland.

Thomas Müller-Späth (T)

YMC ChromaCon, Technoparkstrasse 1, Zürich 8005, Switzerland.

Massimo Morbidelli (M)

Institute for Chemical and Bioengineering, Department of Chemistry and Applied Biosciences, ETH Zurich, Vladimir-Prelog-Weg 1-5/10, Zürich 8093, Switzerland. Electronic address: massimo.morbidelli@polimi.it.

Articles similaires

Humans Amyotrophic Lateral Sclerosis Male Middle Aged Female
Nanoparticles Needles Polylactic Acid-Polyglycolic Acid Copolymer Polyethylene Glycols Curcumin
Humans Epitopes Antibodies, Monoclonal Immunoglobulin Fab Fragments Cryoelectron Microscopy

Antigen targeting and anti-tumor activity of a novel anti-CD146

Kim Lindland, Marion Masitsa Malenge, Ruth Gong Li et al.
1.00
Animals Humans CD146 Antigen Mice Immunoconjugates

Classifications MeSH